Company profile
Verde Science, Inc.
OTC: VRCI · Healthcare · Biotechnology
#1161 of 1,418 Healthcare companies by revenuebottom-decile growth
EA Score
——FH —DQ 10GM —SS 24
v0.1 · 25/100 weight · pillars only
↑ listing tenure, Piotroski F · ↓ workforce scale, revenue growth (YoY)
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$2.6M
Employees
1
as of 2026-08-31
Market cap
$477
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$0$02013
Net income-$2.6M-$2.6M2014
Operating income-$1.9M-$1.9M2014
Total assets$128$1282014
Liabilities$794.6k$794.6k2014
Equity-$794.5k-$794.5k2014
Revenue trend
FY2011 – FY2013 · USD
FY11
FY11
FY12
FY13
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Verde Science, Inc.’s revenue?
Verde Science, Inc. booked $0 in FY2013 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
North Bud Farms Inc.——OncoSec Medical Incorporated——Cannabiz Mobile, Inc.——Lexington Biosciences, Inc.——Thoughtful Brands Inc.——Greenwind Holdings Inc.——Neighbors
Dallas →Key facts
CEOHarpreet Singh Sangha
SectorHealthcare
IndustryBiotechnology
HeadquartersDallas, TX
ExchangeOTC: VRCI
Employees1
IPO date2009-02-10
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.